Oxidative Stress in Non-Dialysis-Dependent Chronic Kidney Disease Patients

被引:13
|
作者
Tomas-Simo, Patricia [1 ]
D'Marco, Luis [1 ]
Romero-Parra, Maria [1 ]
Tormos-Munoz, Mari Carmen [2 ]
Saez, Guillermo [2 ]
Torregrosa, Isidro [1 ]
Estan-Capell, Nuria [2 ]
Miguel, Alfonso [1 ]
Gorriz, Jose Luis [1 ]
Jesus Puchades, Maria [1 ]
机构
[1] Univ Valencia, Hosp Clin Univ, Nephrol Dept, INCLIVA, Valencia 46010, Spain
[2] Univ Valencia, Hosp Univ Dr Peset, Fac Med & Odontol INCLIVA, Serv Clin Anal,Dept Biochem & Mol Biol,FISABIO, Valencia 46010, Spain
关键词
oxidative stress; chronic kidney disease; cardiovascular disease; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR MORTALITY; HEMODIALYSIS; DNA; 8-HYDROXY-2'-DEOXYGUANOSINE; DAMAGE; GLUTATHIONE; MORBIDITY; MARKER;
D O I
10.3390/ijerph18157806
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Cardiovascular complications are the leading cause of morbidity and mortality at any stage of chronic kidney disease (CKD). Moreover, the high rate of cardiovascular mortality observed in these patients is associated with an accelerated atherosclerosis process that likely starts at the early stages of CKD. Thus, traditional and non-traditional or uremic-related factors represent a link between CKD and cardiovascular risk. Among non-conventional risk factors, particular focus has been placed on anaemia, mineral and bone disorders, inflammation, malnutrition and oxidative stress and, in this regard, connections have been reported between oxidative stress and cardiovascular disease in dialysis patients. Methods: We evaluated the oxidation process in different molecular lines (proteins, lipids and genetic material) in 155 non-dialysis patients at different stages of CKD and 45 healthy controls. To assess oxidative stress status, we analyzed oxidized glutathione (GSSG), reduced glutathione (GSH) and the oxidized/reduced glutathione ratio (GSSG/GSH) and other oxidation indicators, including malondialdehyde (MDA) and 8-oxo-2'-deoxyguanosine (8-oxo-dG). Results: An active grade of oxidative stress was found from the early stages of CKD onwards, which affected all of the molecular lines studied. We observed a heightened oxidative state (indicated by a higher level of oxidized molecules together with decreased levels of antioxidant molecules) as kidney function declined. Furthermore, oxidative stress-related alterations were significantly greater in CKD patients than in the control group. Conclusions: CKD patients exhibit significantly higher oxidative stress than healthy individuals, and these alterations intensify as eGFR declines, showing significant differences between CKD stages. Thus, future research is warranted to provide clearer results in this area.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease
    Bunn, H. Franklin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16):
  • [2] Iron and Clinical Outcomes in Dialysis and Non-Dialysis-Dependent Chronic Kidney Disease Patients
    Kovesdy, Csaba P.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (02) : 109 - 116
  • [3] Morphological brain alterations in dialysis- and non-dialysis-dependent patients with chronic kidney disease
    Huan Yu
    Chaoyang Zhang
    Yan Cai
    Ning Wu
    Xiuqin Jia
    Jiaojiao Wu
    Feng Shi
    Rui Hua
    Qi Yang
    [J]. Metabolic Brain Disease, 2023, 38 : 1311 - 1321
  • [4] Ferric Derisomaltose Evaluation in Patients with Non-Dialysis-Dependent Chronic Kidney Disease or Peritoneal Dialysis
    England, Emma
    Sheffield, Maneka
    Poyah, Penelope
    Clark, David
    Wilson, Jo-Anne
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2023, 76 (02): : 94 - 101
  • [5] Morphological brain alterations in dialysis- and non-dialysis-dependent patients with chronic kidney disease
    Yu, Huan
    Zhang, Chaoyang
    Cai, Yan
    Wu, Ning
    Jia, Xiuqin
    Wu, Jiaojiao
    Shi, Feng
    Hua, Rui
    Yang, Qi
    [J]. METABOLIC BRAIN DISEASE, 2023, 38 (04) : 1311 - 1321
  • [6] Initiation of Darbepoetin for Management of Anemia in Non-dialysis-dependent Patients with Chronic Kidney Disease
    Al Raisi, Fatma
    Al Salmi, Issa
    Kamble, Pramod
    Al Shehri, Muna
    Shaheen, Faissal A. M.
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (06) : 1182 - 1187
  • [7] HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE
    Koury, Mark
    Pergola, Pablo E.
    Roy-Chaudhury, Prabir
    Farag, Youssef
    Vargo, Dennis
    Luo, Wenli
    Winkelmayer, Wolfgang
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [8] The Management of Non-Dialysis-Dependent Chronic Kidney Disease in Primary Care
    Weckmann, Gesine
    Chenot, Jean-Francois
    Stracke, Sylvia
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (44): : 745 - +
  • [9] PULMONARY HYPERTENSION AS A FACTOR FOR CARDIAC REMODELING IN NON-DIALYSIS-DEPENDENT AND DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS
    Vasilieva, Maria
    Rudenko, Tatiana
    Shvetsov, Mikhail
    Solomakhina, Nina
    Kutyrina, Irina
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 120 - 121
  • [10] Medical Nutrition Therapy for Patients with Non-Dialysis-Dependent Chronic Kidney Disease: Barriers and Solutions
    Kramer, Holly
    Jimenez, Elizabeth Yakes
    Brommage, Deborah
    Vassalotti, Joseph
    Montgomery, Elizabeth
    Steiber, Alison
    Schofield, Marsha
    [J]. JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2018, 118 (10) : 1958 - 1965